The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Management of chronic HBV-HDV patients chronic HBV-HDV infection: A review on new management options
United European Gastroenterol J. 2023 Dec 2. doi: 10.1002/ueg2.12494.Online ahead of print.
1Liver Unit, Internal Medicine Department, Hospital Universitari Valld'Hebron, Valld'Hebron Barcelona Hospital Campus, Barcelona, Spain.
2Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
3CIBERehd, Instituto Carlos III, Barcelona, Spain.
4Liver Unit, Saint Joseph Hopital, Marseille, France.
5Aix Marseille University, Inserm, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Abstract
Hepatitis D virus was first described by Mario Rizzeto in 1977, and it is considered chronic viral hepatitis with the poorest prognosis. Despite its discovery almost 50 years ago, progress in its diagnosis and treatment has been scarce until recent years. The approval of bulevirtide has shed some light for patients with Chronic Hepatitis D, although important gaps regarding its use in therapy as well as about the epidemiology and diagnosis of the disease need to be addressed.
Stay Informed!
